Search

Your search keyword '"P. Horby"' showing total 401 results

Search Constraints

Start Over You searched for: Author "P. Horby" Remove constraint Author: "P. Horby"
401 results on '"P. Horby"'

Search Results

1. An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial—an update to the published protocol

2. Clinical trial results in context: comparison of baseline characteristics and outcomes of 38,510 RECOVERY trial participants versus a reference population of 346,271 people hospitalised with COVID-19 in England

3. Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

4. Long Covid: a global health issue – a prospective, cohort study set in four continents

5. Stratified analyses refine association between TLR7 rare variants and severe COVID-19

6. An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus an aminoglycoside + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial—an update to the published protocol

7. Clinical trial results in context: comparison of baseline characteristics and outcomes of 38,510 RECOVERY trial participants versus a reference population of 346,271 people hospitalised with COVID-19 in England

8. Perpetual Observational Studies: New strategies to support efficient implementation of observational studies and randomized trials in the infectious diseases arena

9. Preparing for pandemics: a systematic review of pandemic influenza clinical management guidelines.

10. Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

11. The burden and dynamics of hospital-acquired SARS-CoV-2 in England

12. Influenza A(H1N1)pdm09 But Not A(H3N2) Virus Infection Induces Durable Seroprotection: Results From the Ha Nam Cohort.

13. Availability, scope and quality of monkeypox clinical management guidelines globally: a systematic review.

14. Characteristics and outcomes of COVID-19 patients admitted to hospital with and without respiratory symptoms

15. Evaluation of pragmatic oxygenation measurement as a proxy for Covid-19 severity

16. GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

17. Expanded Access Programme for the use of tecovirimat for the treatment of monkeypox infection: A study protocol for an Expanded Access Programme.

18. Mpox: The alarm went off. Have we gone back to sleep?

19. Evaluation of pragmatic oxygenation measurement as a proxy for Covid-19 severity

20. MOSAIC: A cohort study of human mpox virus disease [version 3; peer review: 2 approved]

21. MOSAIC: A cohort study of human mpox virus disease [version 2; peer review: 2 approved]

22. A minimal common outcome measure set for COVID-19 clinical research

23. Seroepidemiology of enterovirus A71 infection in prospective cohort studies of children in southern China, 2013-2018

24. Preparing for pandemics: a systematic review of pandemic influenza clinical management guidelines

25. Human infection with a reassortment avian influenza A H3N8 virus: an epidemiological investigation study

26. Whole-genome sequencing reveals host factors underlying critical COVID-19

27. Lack of Evidence for Ribavirin Treatment of Lassa Fever in Systematic Review of Published and Unpublished Studies

28. Seroepidemiology of Lassa virus in pregnant women in Southern Nigeria: A prospective hospital-based cohort study.

29. Transplacental transfer of Lassa IgG antibodies in pregnant women in Southern Nigeria: A prospective hospital-based cohort study.

30. Author Correction: GWAS and meta-analysis identifies 49 genetic variants underlying critical COVID-19

32. Seroepidemiology of enterovirus A71 infection in prospective cohort studies of children in southern China, 2013-2018

33. An evaluation of global Chikungunya clinical management guidelines: A systematic review

34. Paediatric COVID-19 mortality: a database analysis of the impact of health resource disparity

35. An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients

36. Seroprevalence and Virologic Surveillance of Enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006–2017

37. Preprints in times of COVID19: the time is ripe for agreeing on terminology and good practices

38. Presentation and Outcomes of Lassa Fever in Children in Nigeria: A Prospective Cohort Study (LASCOPE)

39. Sodium–glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials

40. Availability, scope and quality of monkeypox clinical management guidelines globally: a systematic review

41. Chemoprophylaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations

42. Potential health and economic impacts of dexamethasone treatment for patients with COVID-19

43. Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

44. How the COVID-19 pandemic will change the future of critical care

45. Ebola virus antibody decay–stimulation in a high proportion of survivors

46. Serological evidence of human infections with highly pathogenic avian influenza A(H5N1) virus: a systematic review and meta-analysis

47. Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009

48. An open-label, randomized, non-inferiority trial of the efficacy and safety of ciprofloxacin versus streptomycin + ciprofloxacin in the treatment of bubonic plague (IMASOY): study protocol for a randomized control trial

49. Addressing challenges for clinical research responses to emerging epidemics and pandemics: a scoping review

50. Evaluation of the efficacy and safety of intravenous remdesivir in adult patients with severe COVID-19: study protocol for a phase 3 randomized, double-blind, placebo-controlled, multicentre trial

Catalog

Books, media, physical & digital resources